TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07290985: AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas

Sponsor: American Association for Cancer Research · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 242 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$14,784,000

Rescue Site Savings

+$9,748,200

Unlock Full NCT07290985 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07290985 Rescue Dossier →